ETHYL 2-(PYRIDIN-4-YL)THIAZOLE-4-CARBOXYLATE, 95.0%, 100mg

2,5-Dimethyl-1-(propan-2-yl)-1h-pyrrole-3-carboxylic acid, 95+%, 100mg

4-(1,1-Difluoroethyl)picolinic acid, 95%, 1g

6-(Trifluoromethyl)-1H-benzo[d]imidazole, 95.0%, 5g

3-Aminoisonicotinamide, 97.0%, 5g

3-Bromobenzene-1,2-diamine, 95.0%, 1g

1-(2-Amino-6-(3,5-dimethoxyphenyl)pyrido[2,3-d]pyrimidin-7-yl)-3-(tert-butyl)urea, 95.0%, 25mg

h-Homoarginine, 95.0%, 1g

3-Iodo-6-methylpyridazine, 95.0%, 1g

Metilimidazol, mínimo 99%, para síntesis, 100 ml, envase de vidrio

N-(3-Bromo-4-fluorophenyl)acetamide, 95.0%, 25g

(2-(4-Fluorophenyl)cyclopropyl)methanamine hydrochloride, 98%, 250mg

2-(3-Bromo-4-methoxyphenyl)-2-methyl-1,3-dioxolane, 98%, 10g